SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.190
+0.020 (0.63%)
Nov 21, 2024, 1:23 PM EST - Market open
Company Description
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space.
The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.
SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
SOPHiA GENETICS SA
Country | Switzerland |
Founded | 2011 |
IPO Date | Jul 23, 2021 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 430 |
CEO | Jurgi Camblong |
Contact Details
Address: La PiEce 12 Rolle, 1180 Switzerland | |
Phone | 41 21 694 10 60 |
Website | sophiagenetics.com |
Stock Details
Ticker Symbol | SOPH |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $18.00 |
CIK Code | 0001840706 |
CUSIP Number | H82027105 |
ISIN Number | CH1125843347 |
SIC Code | 7374 |
Key Executives
Name | Position |
---|---|
Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder, Chief Executive Officer and Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 19, 2024 | 144 | Filing |
Nov 19, 2024 | 144 | Filing |
Nov 19, 2024 | 144 | Filing |
Nov 19, 2024 | 144 | Filing |
Nov 19, 2024 | 144 | Filing |
Nov 19, 2024 | 144 | Filing |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 5, 2024 | 6-K | Report of foreign issuer |
Nov 5, 2024 | 6-K | Report of foreign issuer |
Oct 22, 2024 | 144 | Filing |